Published in TB and Outbreaks Week, April 3rd, 2001
The answer appears to be yes - if an area is endemic for the parasitic infection.
Researchers investigated whether the cost of large-scale Lyme disease vaccination is worthwhile in terms of quality of life gained due to disease avoidance.
"We developed a decision-analytic model to evaluate the cost-effectiveness of vaccination compared with no vaccination in individuals living in endemic areas of Lyme disease," reported N.A. Shadick and colleagues at Brigham and Women's...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of TB and Outbreaks Week
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.